Advertisement

Economics of Preventing, Screening, and Treating Oral Cancers

  • Sujha SubramanianEmail author
  • K. Krishnakumar
Chapter

Abstract

Oral cancers are the commonest among all head and neck squamous cell cancers (HNSCC). Cancers of the oral cavity in the developing world differ from those in the Western world in terms of age, subsites of disease, etiology, and molecular biology. Poverty, illiteracy, advanced stage at presentation, lack of access to healthcare, and poor treatment infrastructure are also major challenges. The annual GDP (gross domestic product) spent on healthcare is very low in the low-resource countries compared to high-income countries [1].

References

  1. 1.
    Joshi P, Dutta S, Chaturvedi P, Nair S. Head and neck cancers in developing countries. Rambam Maimonides Med J. 2014;5(2):e0009. doi: 10.5041/RMMJ.10143. eCollection 2014 Apr.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. JAMA. 1996;276(14):1172–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Edejer TT, Baltussen R, Adam T, Hutubessey R, Acharya A, Evand DB, CJL M. WHO guide to cost-effectiveness analysis. Geneva: WHO; 2003.Google Scholar
  4. 4.
    Robberstad B. QALYs vs DALYs vs LYs gained: what are the differences, and what difference do they make for health care priority setting? Norwegian J Epidemiol. 2005;15(2):183–91.Google Scholar
  5. 5.
    Smith MD, Drummond M, Brixner D. Moving the QALY forward: rationale for change. Value Health. 2009;12(Suppl 1):S1–4.CrossRefGoogle Scholar
  6. 6.
    Petersen PE. Oral cancer prevention and control--the approach of the World Health Organization. Oral Oncol. 2009;45(4–5):454–60.CrossRefPubMedGoogle Scholar
  7. 7.
    Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009;373(9682):2234–46. doi: 10.1016/S0140-6736(09)60744-3.CrossRefPubMedGoogle Scholar
  8. 8.
    Laxminarayan R, Chow J, Shahid-Salles SA. In: Jamison DT, Breman JG, Measham AR, et al., editors. Intervention cost-effectiveness: overview of main messages in disease control priorities in developing countries. 2nd ed. Washington, DC: World Bank; 2006.Google Scholar
  9. 9.
    Ranson K, Jha P, Chaloupka FJ, Nguyen S. The effectiveness and cost-effectiveness of price increases and other tobacco-control policies. In: Jha P, Chaloupka F, editors. Tobacco control in developing countries. Oxford, UK: Oxford University Press; 2000.Google Scholar
  10. 10.
    Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G, Mathew B, Vinoda J, Ramadas K. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ. 2009;87(3):200–6.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Dedhia RC, Smith KJ, Johnson JT, Roberts M. The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: a Markov decision analysis approach. Laryngoscope. 2011;121(5):952–60. doi: 10.1002/lary.21412. Epub 2011 Mar 7.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess. 2006;10:1–144.CrossRefPubMedGoogle Scholar
  13. 13.
    van der Meij EH, Bezemer PD, van der Waal I. Cost-effectiveness of screening for the possible development of cancer in patients with oral lichen planus. Community Dent Oral Epidemiol. 2002;30(5):342–51.CrossRefPubMedGoogle Scholar
  14. 14.
    Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, NR MM, Hughes M. Head and neck cancers, version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2014;12(10):1454–87.CrossRefGoogle Scholar
  15. 15.
    Newman H, Albooz H. The Scottish Intercollegiate Guidelines Network (SIGN) guideline for head and neck cancer: pointing in the right direction? Clin Oncol(R Coll Radiol). 2008;20(9):664–5.CrossRefGoogle Scholar
  16. 16.
    Diagnosis and management of head and neck cancer, Guideline No. 90 ISBN 9781905813001 November 2006. www.sign.ac.uk/guidelines/.
  17. 17.
    Guidance. nice.org.uk/CSGHN.
  18. 18.
    Grégoire V, Lefebvre JL, Licitra L, Felip E, EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v184–6.CrossRefPubMedGoogle Scholar
  19. 19.
    American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, Clayman GL, Fisher SG, Forastiere AA, Harrison LB, Lefebvre JL, Leupold N, List MA, O'Malley BO, Patel S, Posner MR, Schwartz MA, Wolf GT. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol. 2006 Aug 1;24(22):3693–704.CrossRefGoogle Scholar
  20. 20.
    Improving outcomes in head and neck cancers: Evidence Update May 2012 available from www.evidence.nhs.uk/topic/head-and-neck-cancers.
  21. 21.
    Indian council of medical research (ICMR): Guidelines for Management of Buccal Mucosa Cancer, 2010.Google Scholar
  22. 22.
    Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A, Carlson RW, Azavedo E, Harford J. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer. 2008;113(8 Suppl):2221–43.CrossRefPubMedGoogle Scholar
  23. 23.
    Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS, Chow LW, Masood S, Ramsey SD, Carlson RW. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006;12(Suppl 1):S3–15.CrossRefPubMedGoogle Scholar
  24. 24.
    Wee JT, Anderson BO, Corry J, D'Cruz A, Soo KC, Qian CN, Chua DT, Hicks RJ, Goh CH, Khoo JB, Ong SC, Forastiere AA, Chan AT, Asian Oncology Summit. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10(11):1086–92.CrossRefPubMedGoogle Scholar
  25. 25.
    Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, Park SR, Fujii M, Kang YK, Chen LT. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e535–47.CrossRefPubMedGoogle Scholar
  26. 26.
    Tan D, Tan SY, Lim ST, Kim SJ, Kim WS, Advani R, Kwong YL. Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e548–61.CrossRefPubMedGoogle Scholar
  27. 27.
    Williams S, Chiong E, Lojanapiwat B, Umbas R, Akaza H, Asian Oncology Summit 2013. Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol. 2013;14(12):e524–34.CrossRefPubMedGoogle Scholar
  28. 28.
    Yeoh AE, Tan D, Li CK, Hori H, Tse E, Pui CH, Asian Oncology Summit 2013. Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol. 2013;14(12):e508–23.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Lertkhachonsuk AA, Yip CH, Khuhaprema T, Chen DS, Plummer M, Jee SH, Toi M, Wilailak S, Asian Oncology Summit 2013. Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol. 2013;14(12):e497–507.CrossRefPubMedGoogle Scholar
  30. 30.
    Payne S, Chan N, Davies A, Poon E, Connor S, Goh C. Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol. 2012;13(11):e492–500.CrossRefPubMedGoogle Scholar
  31. 31.
    Chiong E, Tay MH, Tan MH, Kumar S, Sim HG, Teh BT, Umbas R, Chau NM. Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol. 2012;13(11):e482–91.CrossRefPubMedGoogle Scholar
  32. 32.
    Ku G, Tan IB, Yau T, Boku N, Laohavinij S, Cheng AL, Kang YK, de Lima Lopes G Jr. Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol. 2012;13(11):e470–81.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.RTI InternationalWalthamUSA
  2. 2.Head and Neck Surgery and OncologyAmrita Institute of Medical SciencesKochiIndia

Personalised recommendations